Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.20.1
Income Taxes
12 Months Ended
Dec. 28, 2019
Income Taxes  
Income Taxes

Note 7 – Income Taxes

The components of income (loss) from continuing operations before income tax provision consist of the following:

 

 

 

 

 

 

 

 

 

Fiscal Year Ended

 

    

December 28, 2019

    

December 29, 2018

Domestic operations

 

$

(10,618)

 

$

(5,697)

Foreign operations

 

 

507

 

 

479

Total (loss) income before income taxes

 

$

(10,111)

 

$

(5,218)

 

Income tax (benefit) provision for fiscal year 2019 and 2018 consists of the following:

 

 

 

 

 

 

 

 

 

Fiscal Year Ended

 

    

December 28, 2019

    

December 29, 2018

Current:

 

 

  

 

 

  

State tax

 

$

 6

 

$

 6

Foreign tax

 

 

144

 

 

111

Total current taxes

 

 

150

 

 

117

Deferred:

 

 

  

 

 

  

Federal tax

 

 

(1,311)

 

 

(490)

State tax

 

 

(417)

 

 

537

Total deferred taxes

 

 

(1,728)

 

 

47

Change in federal tax rate - deferred tax impact

 

 

 

 

 

 —

Valuation allowance

 

 

23,015

 

 

(493)

Income tax (benefit) provision

 

$

21,437

 

$

(329)

 

Income tax (benefit) provision differs from the amount that would result from applying the federal statutory rate as follows:

 

 

 

 

 

 

 

 

    

December 28, 2019

    

December 29, 2018

Income tax at U.S. federal statutory rate

 

$

(2,123)

 

$

(1,096)

Tax attributes written off

 

 

 —

 

 

522

Share-based compensation

 

 

729

 

 

727

State income tax, net of federal tax effect

 

 

(325)

 

 

(66)

Foreign tax

 

 

106

 

 

68

Other

 

 

35

 

 

 9

Change in valuation allowance

 

 

23,015

 

 

(493)

Effective tax (benefit) provision

 

$

21,437

 

$

(329)

 

For fiscal years 2019 and 2018 the effective tax rate for the Company was (212.0)% and 6.3%, respectively. The Company’s effective tax rate for fiscal years 2019 differs from the U.S. federal rate primarily as a result of non-deductible share-based compensation, the write-off of expired state net operating loss carryforwards, and the change in the valuation allowance maintained against the Company’s deferred tax assets.

Deferred tax assets and deferred tax liabilities consisted of the following:

 

 

 

 

 

 

 

 

    

December 28, 2019

    

December 29, 2018

Deferred tax assets:

 

 

  

 

 

  

Inventory and inventory related allowance

 

$

529

 

$

639

Share-based compensation

 

 

1,836

 

 

2,119

Intangibles

 

 

1,577

 

 

2,415

Sales and bad debt allowances

 

 

712

 

 

718

Vacation accrual

 

 

200

 

 

202

Book over tax amortization on property and equipment

 

 

 —

 

 

193

Net operating loss

 

 

25,322

 

 

21,345

Other

 

 

 1

 

 

86

Total deferred tax assets

 

 

30,177

 

 

27,717

Valuation Allowance

 

 

(29,731)

 

 

(5,816)

Net deferred tax assets

 

 

446

 

 

21,901

Deferred tax liabilities:

 

 

  

 

 

  

Tax over book depreciation

 

 

398

 

 

 —

Prepaid catalog expenses

 

 

48

 

 

68

Total deferred tax liabilities

 

 

446

 

 

68

Net deferred tax assets

 

$

 —

 

$

21,833

 

At December 28, 2019, federal and state net operating loss (“NOL”) carryforwards were $85,830 and $79,644, respectively. Federal NOL carryforwards of $2,106 were acquired in the acquisition of WAG which are subject to Internal Revenue Code section 382 and limited to an annual usage limitation of $135. Federal NOL carryforwards begin to expire in 2029. The state NOL carryforwards expire in the respective tax years as follows:

 

 

 

 

2020

    

$

539

2021

 

 

5,345

2022

 

 

975

2023

 

 

3,028

2024

 

 

2,358

Thereafter

 

 

67,399

 

 

$

79,644

 

Under the provisions of ASC 740, management is required to evaluate whether a valuation allowance should be established against its deferred tax assets based on the consideration of all available evidence using a “more likely than not” standard. Realization of deferred tax assets is dependent upon taxable income in prior carryback years, estimates of future taxable income, tax planning strategies, and reversal of existing taxable temporary differences. ASC 740 provides that forming a conclusion that a valuation allowance is not needed is difficult when there is negative evidence such as cumulative losses in recent years or losses expected in early future years. As of December 28, 2019, in part because in the year then ended the Company reached three years of cumulative pre-tax loss in the U.S federal tax jurisdiction, management considered it appropriate to record additional valuation allowance of approximately $23,015 against our deferred tax assets. As of December 28, 2019 the Company maintained a valuation allowance in the amount of $29,731 against deferred tax assets that were not more likely than not of being realized.

We are subject to U.S. federal income tax as well as income tax of foreign and state tax jurisdictions. The tax years 2015‑2019 remain open to examination by the major taxing jurisdictions to which the Company is subject, except the Internal Revenue Service for which the tax years 2016‑2019 remain open. The Company does not anticipate a significant change to the amount of unrecognized tax benefits within the next twelve months.

Included in accrued expenses are income taxes payable of $33 and $23 for the fiscal year 2019 and 2018 respectively, consisting primarily of current foreign taxes. Included in other non-current liabilities are income taxes payable of $662 and $614 for the fiscal year 2019 and 2018, respectively, relating to future foreign withholding taxes.